Correlation Between Clal Biotechnology and Lineage Cell
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Lineage Cell Therapeutics, you can compare the effects of market volatilities on Clal Biotechnology and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Lineage Cell.
Diversification Opportunities for Clal Biotechnology and Lineage Cell
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Clal and Lineage is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Lineage Cell go up and down completely randomly.
Pair Corralation between Clal Biotechnology and Lineage Cell
Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to generate 1.33 times more return on investment than Lineage Cell. However, Clal Biotechnology is 1.33 times more volatile than Lineage Cell Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Lineage Cell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 3,940 in Clal Biotechnology Industries on September 5, 2024 and sell it today you would lose (400.00) from holding Clal Biotechnology Industries or give up 10.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.94% |
| Values | Daily Returns |
Clal Biotechnology Industries vs. Lineage Cell Therapeutics
Performance |
| Timeline |
| Clal Biotechnology |
| Lineage Cell Therapeutics |
Clal Biotechnology and Lineage Cell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Clal Biotechnology and Lineage Cell
The main advantage of trading using opposite Clal Biotechnology and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.| Clal Biotechnology vs. Bezeq Israeli Telecommunication | Clal Biotechnology vs. El Al Israel | Clal Biotechnology vs. Bank Leumi Le Israel | Clal Biotechnology vs. Elbit Systems |
| Lineage Cell vs. Purple Biotech | Lineage Cell vs. BioLine RX | Lineage Cell vs. Clal Biotechnology Industries | Lineage Cell vs. Evogene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |